For example, increased activity of the ERK1/2 pathway has been identified in type 2 diabetes mellitus (Tanti & Jager, 2009) and hypertension (Roberts, 2012), which are major risk factors for cardiovascular disorders. Here, MAPK3 is linked to cardiovascular disorder.